Real-time PCR Molecular Diagnostics has high sensitivity, higher accuracy and less pollution, and can process test results in a timely manner, thus limiting the error range.

The global PCR and Real-time PCR Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for PCR and Real-time PCR Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCR and Real-time PCR Molecular Diagnostics.

Report Scope

The PCR and Real-time PCR Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PCR and Real-time PCR Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PCR and Real-time PCR Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of PCR and Real-time PCR Molecular Diagnostics Market Report

Report Metric	Details
Report Name	PCR and Real-time PCR Molecular Diagnostics Market
CAGR	5%
Segment by Type	Instruments Reagents Consumables
Segment by Application	Infectious Diseases Testing Oncology Testing Genetic Testing Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, bioMereieux SA, Danaher Corporation, Bio-Rad Laboratories, QIAGEN N.V, F-Hoffmann-La Roche Ltd., Genomic Health, GRIFOLS S.A, Thermo Fisher Scientific Inc., Seegene Inc., Hologic Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PCR and Real-time PCR Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PCR and Real-time PCR Molecular Diagnostics Market report?

Ans: The main players in the PCR and Real-time PCR Molecular Diagnostics Market are Abbott Laboratories, bioMereieux SA, Danaher Corporation, Bio-Rad Laboratories, QIAGEN N.V, F-Hoffmann-La Roche Ltd., Genomic Health, GRIFOLS S.A, Thermo Fisher Scientific Inc., Seegene Inc., Hologic Inc.

What are the Application segmentation covered in the PCR and Real-time PCR Molecular Diagnostics Market report?

Ans: The Applications covered in the PCR and Real-time PCR Molecular Diagnostics Market report are Infectious Diseases Testing, Oncology Testing, Genetic Testing, Others

What are the Type segmentation covered in the PCR and Real-time PCR Molecular Diagnostics Market report?

Ans: The Types covered in the PCR and Real-time PCR Molecular Diagnostics Market report are Instruments, Reagents, Consumables

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Instruments

1.2.3 Reagents

1.2.4 Consumables

1.3 Market by Application

1.3.1 Global PCR and Real-time PCR Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Infectious Diseases Testing

1.3.3 Oncology Testing

1.3.4 Genetic Testing

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global PCR and Real-time PCR Molecular Diagnostics Market Perspective (2019-2030)

2.2 PCR and Real-time PCR Molecular Diagnostics Growth Trends by Region

2.2.1 Global PCR and Real-time PCR Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 PCR and Real-time PCR Molecular Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 PCR and Real-time PCR Molecular Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 PCR and Real-time PCR Molecular Diagnostics Market Dynamics

2.3.1 PCR and Real-time PCR Molecular Diagnostics Industry Trends

2.3.2 PCR and Real-time PCR Molecular Diagnostics Market Drivers

2.3.3 PCR and Real-time PCR Molecular Diagnostics Market Challenges

2.3.4 PCR and Real-time PCR Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top PCR and Real-time PCR Molecular Diagnostics Players by Revenue

3.1.1 Global Top PCR and Real-time PCR Molecular Diagnostics Players by Revenue (2019-2024)

3.1.2 Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global PCR and Real-time PCR Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by PCR and Real-time PCR Molecular Diagnostics Revenue

3.4 Global PCR and Real-time PCR Molecular Diagnostics Market Concentration Ratio

3.4.1 Global PCR and Real-time PCR Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by PCR and Real-time PCR Molecular Diagnostics Revenue in 2023

3.5 PCR and Real-time PCR Molecular Diagnostics Key Players Head office and Area Served

3.6 Key Players PCR and Real-time PCR Molecular Diagnostics Product Solution and Service

3.7 Date of Enter into PCR and Real-time PCR Molecular Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 PCR and Real-time PCR Molecular Diagnostics Breakdown Data by Type

4.1 Global PCR and Real-time PCR Molecular Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global PCR and Real-time PCR Molecular Diagnostics Forecasted Market Size by Type (2025-2030)

5 PCR and Real-time PCR Molecular Diagnostics Breakdown Data by Application

5.1 Global PCR and Real-time PCR Molecular Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global PCR and Real-time PCR Molecular Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America PCR and Real-time PCR Molecular Diagnostics Market Size (2019-2030)

6.2 North America PCR and Real-time PCR Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024)

6.4 North America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe PCR and Real-time PCR Molecular Diagnostics Market Size (2019-2030)

7.2 Europe PCR and Real-time PCR Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024)

7.4 Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America PCR and Real-time PCR Molecular Diagnostics Market Size (2019-2030)

9.2 Latin America PCR and Real-time PCR Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024)

9.4 Latin America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Introduction

11.1.4 Abbott Laboratories Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 bioMereieux SA

11.2.1 bioMereieux SA Company Detail

11.2.2 bioMereieux SA Business Overview

11.2.3 bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Introduction

11.2.4 bioMereieux SA Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.2.5 bioMereieux SA Recent Development

11.3 Danaher Corporation

11.3.1 Danaher Corporation Company Detail

11.3.2 Danaher Corporation Business Overview

11.3.3 Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Introduction

11.3.4 Danaher Corporation Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.3.5 Danaher Corporation Recent Development

11.4 Bio-Rad Laboratories

11.4.1 Bio-Rad Laboratories Company Detail

11.4.2 Bio-Rad Laboratories Business Overview

11.4.3 Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Introduction

11.4.4 Bio-Rad Laboratories Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.4.5 Bio-Rad Laboratories Recent Development

11.5 QIAGEN N.V

11.5.1 QIAGEN N.V Company Detail

11.5.2 QIAGEN N.V Business Overview

11.5.3 QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Introduction

11.5.4 QIAGEN N.V Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.5.5 QIAGEN N.V Recent Development

11.6 F-Hoffmann-La Roche Ltd.

11.6.1 F-Hoffmann-La Roche Ltd. Company Detail

11.6.2 F-Hoffmann-La Roche Ltd. Business Overview

11.6.3 F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Introduction

11.6.4 F-Hoffmann-La Roche Ltd. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.6.5 F-Hoffmann-La Roche Ltd. Recent Development

11.7 Genomic Health

11.7.1 Genomic Health Company Detail

11.7.2 Genomic Health Business Overview

11.7.3 Genomic Health PCR and Real-time PCR Molecular Diagnostics Introduction

11.7.4 Genomic Health Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.7.5 Genomic Health Recent Development

11.8 GRIFOLS S.A

11.8.1 GRIFOLS S.A Company Detail

11.8.2 GRIFOLS S.A Business Overview

11.8.3 GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Introduction

11.8.4 GRIFOLS S.A Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.8.5 GRIFOLS S.A Recent Development

11.9 Thermo Fisher Scientific Inc.

11.9.1 Thermo Fisher Scientific Inc. Company Detail

11.9.2 Thermo Fisher Scientific Inc. Business Overview

11.9.3 Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Introduction

11.9.4 Thermo Fisher Scientific Inc. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.9.5 Thermo Fisher Scientific Inc. Recent Development

11.10 Seegene Inc.

11.10.1 Seegene Inc. Company Detail

11.10.2 Seegene Inc. Business Overview

11.10.3 Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Introduction

11.10.4 Seegene Inc. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.10.5 Seegene Inc. Recent Development

11.11 Hologic Inc.

11.11.1 Hologic Inc. Company Detail

11.11.2 Hologic Inc. Business Overview

11.11.3 Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Introduction

11.11.4 Hologic Inc. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

11.11.5 Hologic Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Genomic Health

Grifols S A

Thermo Fisher Scientific Inc

Seegene

Hologic Inc

List of Tables

Table 1. Global PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Instruments

Table 3. Key Players of Reagents

Table 4. Key Players of Consumables

Table 5. Global PCR and Real-time PCR Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Region (2019-2024)

Table 9. Global PCR and Real-time PCR Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Region (2025-2030)

Table 11. PCR and Real-time PCR Molecular Diagnostics Market Trends

Table 12. PCR and Real-time PCR Molecular Diagnostics Market Drivers

Table 13. PCR and Real-time PCR Molecular Diagnostics Market Challenges

Table 14. PCR and Real-time PCR Molecular Diagnostics Market Restraints

Table 15. Global PCR and Real-time PCR Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Players (2019-2024)

Table 17. Global Top PCR and Real-time PCR Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and Real-time PCR Molecular Diagnostics as of 2023)

Table 18. Ranking of Global Top PCR and Real-time PCR Molecular Diagnostics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by PCR and Real-time PCR Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players PCR and Real-time PCR Molecular Diagnostics Product Solution and Service

Table 22. Date of Enter into PCR and Real-time PCR Molecular Diagnostics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Type (2019-2024)

Table 26. Global PCR and Real-time PCR Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Type (2025-2030)

Table 28. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Application (2019-2024)

Table 30. Global PCR and Real-time PCR Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Application (2025-2030)

Table 32. North America PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Abbott Laboratories Company Detail

Table 48. Abbott Laboratories Business Overview

Table 49. Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Product

Table 50. Abbott Laboratories Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 51. Abbott Laboratories Recent Development

Table 52. bioMereieux SA Company Detail

Table 53. bioMereieux SA Business Overview

Table 54. bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Product

Table 55. bioMereieux SA Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 56. bioMereieux SA Recent Development

Table 57. Danaher Corporation Company Detail

Table 58. Danaher Corporation Business Overview

Table 59. Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Product

Table 60. Danaher Corporation Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 61. Danaher Corporation Recent Development

Table 62. Bio-Rad Laboratories Company Detail

Table 63. Bio-Rad Laboratories Business Overview

Table 64. Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Product

Table 65. Bio-Rad Laboratories Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 66. Bio-Rad Laboratories Recent Development

Table 67. QIAGEN N.V Company Detail

Table 68. QIAGEN N.V Business Overview

Table 69. QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Product

Table 70. QIAGEN N.V Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 71. QIAGEN N.V Recent Development

Table 72. F-Hoffmann-La Roche Ltd. Company Detail

Table 73. F-Hoffmann-La Roche Ltd. Business Overview

Table 74. F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Product

Table 75. F-Hoffmann-La Roche Ltd. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 76. F-Hoffmann-La Roche Ltd. Recent Development

Table 77. Genomic Health Company Detail

Table 78. Genomic Health Business Overview

Table 79. Genomic Health PCR and Real-time PCR Molecular Diagnostics Product

Table 80. Genomic Health Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 81. Genomic Health Recent Development

Table 82. GRIFOLS S.A Company Detail

Table 83. GRIFOLS S.A Business Overview

Table 84. GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Product

Table 85. GRIFOLS S.A Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 86. GRIFOLS S.A Recent Development

Table 87. Thermo Fisher Scientific Inc. Company Detail

Table 88. Thermo Fisher Scientific Inc. Business Overview

Table 89. Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Product

Table 90. Thermo Fisher Scientific Inc. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 91. Thermo Fisher Scientific Inc. Recent Development

Table 92. Seegene Inc. Company Detail

Table 93. Seegene Inc. Business Overview

Table 94. Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Product

Table 95. Seegene Inc. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 96. Seegene Inc. Recent Development

Table 97. Hologic Inc. Company Detail

Table 98. Hologic Inc. Business Overview

Table 99. Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Product

Table 100. Hologic Inc. Revenue in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024) & (US$ Million)

Table 101. Hologic Inc. Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global PCR and Real-time PCR Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Instruments Features

Figure 4. Reagents Features

Figure 5. Consumables Features

Figure 6. Global PCR and Real-time PCR Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Application: 2023 VS 2030

Figure 8. Infectious Diseases Testing Case Studies

Figure 9. Oncology Testing Case Studies

Figure 10. Genetic Testing Case Studies

Figure 11. Others Case Studies

Figure 12. PCR and Real-time PCR Molecular Diagnostics Report Years Considered

Figure 13. Global PCR and Real-time PCR Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global PCR and Real-time PCR Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Region: 2023 VS 2030

Figure 16. Global PCR and Real-time PCR Molecular Diagnostics Market Share by Players in 2023

Figure 17. Global Top PCR and Real-time PCR Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and Real-time PCR Molecular Diagnostics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by PCR and Real-time PCR Molecular Diagnostics Revenue in 2023

Figure 19. North America PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America PCR and Real-time PCR Molecular Diagnostics Market Share by Country (2019-2030)

Figure 21. United States PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe PCR and Real-time PCR Molecular Diagnostics Market Share by Country (2019-2030)

Figure 25. Germany PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific PCR and Real-time PCR Molecular Diagnostics Market Share by Region (2019-2030)

Figure 33. China PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America PCR and Real-time PCR Molecular Diagnostics Market Share by Country (2019-2030)

Figure 41. Mexico PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Share by Country (2019-2030)

Figure 45. Turkey PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia PCR and Real-time PCR Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Abbott Laboratories Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 48. bioMereieux SA Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 49. Danaher Corporation Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 50. Bio-Rad Laboratories Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 51. QIAGEN N.V Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 52. F-Hoffmann-La Roche Ltd. Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 53. Genomic Health Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 54. GRIFOLS S.A Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 55. Thermo Fisher Scientific Inc. Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 56. Seegene Inc. Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 57. Hologic Inc. Revenue Growth Rate in PCR and Real-time PCR Molecular Diagnostics Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions